LCD ID Number: L37311 Status: A-Approved
LCD Title: MolDX: EndoPredict® Breast Cancer Gene Expression Test
Geographic Jurisdiction: South Dakota Other Jurisdictions
Original Determination Effective Date:
01/30/2018
Original Determination Ending Date:
Revision Effective Date:
07/11/2021
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act, §1862(a)(1)(A) Allows coverage and payment for only those services that are considered to be reasonable and necessary.
42 Code of Federal Regulations (CFR) 410.32(a). Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions
CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|